聯合光電(300691.SZ):聯合汽車被確定為中國一汽部分車型前向毫米波雷達等產品的供應商
格隆匯7月9日丨聯合光電(300691.SZ)公佈,公司之控股子公司中山聯合汽車技術有限公司(以下簡稱"聯合汽車")於近日收到中國第一汽車股份有限公司(以下簡稱"中國一汽")的中標通知及《供應商提名信》,聯合汽車被確定為中國一汽部分車型的前向毫米波雷達、前角毫米波雷達、后角毫米波雷達總成的產品供應商。本次中標項目的採購週期為5年,預計採購總金額為人民幣1.7億元。
根據合作規劃,本項目預計在 2024年年底前開始量產供貨,具體供貨數量及金額尚未確定,預計不會對公司本年度業績產生重大影響,但該項目有利於智能駕駛業務未來年度銷售規模和收入的提升,對公司未來整體經營業績將產生積極影響,具體影響金額及影響時間將視訂單的開展情況而定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.